| Date | Title | Description |
| 08.07.2026 | LinqAlpha Secures $22 Million to Power AI-Driven Market Intelligence | LinqAlpha, a New York-based AI pioneer, just secured $22 million in Series A funding. This significant capital infusion will fuel its mission: building the "Alpha Intelligence Layer" for global public markets. The company's innova... |
| 04.07.2026 | LinqAlpha Raises $22 Million Series A To Build Alpha Intelligence Layer For Global Public Markets | LinqAlpha announced it has raised $22 million in Series A funding to build what it describes as the Alpha Intelligence Layer for global public markets. The funding round was anchored by AVP, Atinum Investment, and GFT Ventures. And the roun... |
| 02.07.2026 | LinqAlpha Raises $22 Million to Build the Alpha Intelligence Layer for Global Public Markets | LinqAlpha turns each investor's own research into AI agents that surface market-moving signals before they are priced in.
NEW YORK, July 2, 2026 /PRNewswire/ -- LinqAlpha, the AI-native company building the Alpha Intelligence Layer for glob... |
| 02.07.2026 | LinqAlpha Raises $22M in Series A Funding | LinqAlpha, a NYC-based AI-native company building the Alpha Intelligence Layer for global public markets, raised $22m in Series A funding.
The round was anchored by AVP, Atinum Investment, and GFT Ventures, with participation from SBI Inves... |
| 14.07.2025 | Illimis Therapeutics Raises $42M in Series B Funding | Illimis Therapeutics, a Seoul, South Korea-based biotechnology company which specializes in central nervous system and immune-related diseases, raised $42M in Series B funding.
Backers included DSC Investment, Woori Venture Partners, Korea ... |
| 14.07.2025 | Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform | Validates technological prowess of GAIA platform and intensifies global co-development effort, including the existing partnership with Lilly Catalyze360-ExploR&D
Funds to accelerate Alzheimer's and immune disease drug development, expan... |
| 18.11.2020 | 10 Korean Startups That Shined in 2020 | With the year slowly coming to a close, let’s take a look back at how ten South Korean startups in 2020 overcame challenges such as COVID-19 and how they changed gears to adapt to the new normal in business and everyday life. It’s been a di... |
